15-Apr-2026
Quant check on David Einhorn's Greenlight Capital holdings post Q1
Seeking Alpha News (Tue, 14-Apr 5:50 AM ET)
Wells Fargo Gives a Buy Rating to Tenet Healthcare (THC)
TipRanks (Mon, 13-Apr 6:56 AM ET)
Tenet to Report its First Quarter 2026 Results on April 30th
Business Wire (Tue, 31-Mar 9:00 AM ET)
Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference
Business Wire (Wed, 4-Mar 9:00 AM ET)
Market Chameleon (Wed, 11-Feb 3:33 AM ET)
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
Business Wire (Wed, 11-Feb 6:45 AM ET)
Tenet Announces Accretive Transaction and Previews Strong 2025 Results
Business Wire (Mon, 2-Feb 6:45 AM ET)
Tenet Healthcare Lifts 2025 Outlook as Adjusted Earnings and Cash Flow Show Strong Growth
Market Chameleon (Tue, 28-Oct 3:47 AM ET)
THC Call Spread Volume Hits $933K—Buyers Target $1.4M Upside Amid Technical Strength
Market Chameleon (Tue, 19-Aug 10:09 AM ET)
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Tenet Healthcare trades on the NYSE stock market under the symbol THC.
As of April 15, 2026, THC stock price declined to $193.56 with 1,169,558 million shares trading.
THC has a beta of 1.12, meaning it tends to be more sensitive to market movements. THC has a correlation of 0.15 to the broad based SPY ETF.
THC has a market cap of $17.01 billion. This is considered a Large Cap stock.
Last quarter Tenet Healthcare reported $6 billion in Revenue and $4.70 earnings per share. This beat revenue expectation by $64 million and exceeded earnings estimates by $.64.
In the last 3 years, THC traded as high as $247.21 and as low as $51.04.
The top ETF exchange traded funds that THC belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
THC has outperformed the market in the last year with a return of +55.0%, while the SPY ETF gained +31.2%. However, in the most recent history, THC shares have underperformed the stock market with its stock returning -0.8% in the last 3 month period and +2.6% for the last 2 week period, while SPY has returned +1.6% and +7.6%, respectively.
THC support price is $191.20 and resistance is $202.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THC shares will trade within this expected range on the day.